This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 12 print issues and online access
$209.00 per year
only $17.42 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
References
Sarafidis PA and Bakris GL (2006) Antihypertensive therapy and the risk of new-onset diabetes. Diabetes Care 29: 1167–1169
Padwal R and Laupacis A (2004) Antihypertensive therapy and incidence of type 2 diabetes: a systematic review. Diabetes Care 27: 247–255
Sarafidis PA and Bakris GL (2006) Antihypertensive treatment with β-blockers and the spectrum of glycaemic control. QJM 99: 431–436
Verdecchia P et al. (2004) Adverse prognostic significance of new diabetes in treated hypertensive subjects. Hypertension 43: 963–969
Kostis JB et al. (2005) Long-term effect of diuretic-based therapy on fatal outcomes in subjects with isolated systolic hypertension with and without diabetes. Am J Cardiol 95: 29–35
Acknowledgements
The synopsis was written by Vicky Heath, Associate Editor, Nature Clinical Practice.
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Competing interests
The authors declare no competing financial interests.
Rights and permissions
About this article
Cite this article
Sarafidis, P., Bakris, G. Are antihypertensive drugs associated with an increased risk of incident type 2 diabetes?. Nat Rev Endocrinol 3, 8–9 (2007). https://doi.org/10.1038/ncpendmet0315
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1038/ncpendmet0315